0001209191-21-019666.txt : 20210310
0001209191-21-019666.hdr.sgml : 20210310
20210310200111
ACCESSION NUMBER: 0001209191-21-019666
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210228
FILED AS OF DATE: 20210310
DATE AS OF CHANGE: 20210310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rodino-Klapac Louise
CENTRAL INDEX KEY: 0001836218
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 21731453
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: STE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-02-28
2021-03-05
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001836218
Rodino-Klapac Louise
215 FIRST STREET
CAMBRIDGE
MA
0
1
0
0
Chief Scientific Officer
Common Stock
2021-02-28
4
F
0
565
86.97
D
6604
D
Common Stock
2021-03-03
4
A
0
15000
0.00
A
21780
D
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.
On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.
The amount of securities directly owned by the reporting person includes 176 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on February 28, 2021.
/s/ Ryan Brown, as Attorney-in-Fact for Louise Rodino-Klapac
2021-03-10